Also trades as: BIVI (NASDAQ) · $vol 5M
BIVIW NASDAQ
BioVie Inc.
1W: +7.0%
YTD: -13.5%
$0.30
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships11
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2021-06-11
Earliest Filing
2025-08-11
Latest Filing
partner: 7
investor: 2
target: 1
acquirer: 1
Counterparties (Filed by BIVIW)
11 relationshipsCompanies named in BIVIW's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| ThinkEquity LLC | — | partner | Sole underwriter for the issuance and sale of 5,620,000 units and 380,000 pre-funded units. | 2025-08-11 | View |
| West Coast Stock Transfer, Inc. | — | partner | Warrant agent appointed to administer the terms and conditions of the Warrants. | 2025-08-11 | View |
| ThinkEquity LLC | — | partner | Placement agent for the issuance and sale of Class A common stock. | 2024-10-29 | View |
| ThinkEquity LLC | — | partner | Placement agent for the issuance and sale of Class A common stock and warrants. | 2024-10-24 | View |
| ThinkEquity LLC | — | partner | Placement agent for the private placement offering of Class A common stock and warrants. | 2024-10-22 | View |
| ThinkEquity LLC | — | partner | Placement agent for the issuance and sale of Class A common stock and warrants. | 2024-09-24 | View |
| Cantor Fitzgerald & Co. | — | partner | Sales agent for the controlled equity offering | 2022-08-31 | View |
| Acuitas Group Holdings, LLC | — | investor | BioVie Inc. issued 3,636,364 shares of Class A common stock and a warrant to Acuitas Group Holdings, LLC in a private pl | 2022-07-18 | View |
| Acuitas Group Holdings, LLC | — | investor | BioVie Inc. issued 3,636,364 shares and warrants to Acuitas in a private placement for approximately $6 million. | 2022-07-15 | View |
| NeurMedix, Inc. | — | target | Target of asset acquisition by BioVie Inc. | 2021-06-11 | View |
| Acuitas Group Holdings, LLC | — | acquirer | Assignee of NeurMedix assets and counterparty in asset purchase agreement. | 2021-06-11 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-14 | Material Agreement; Exhibits | Agreement | View |
| 2026-08-06 | Regulation FD; Exhibits | View | |
| 2025-11-13 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-08-11 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2025-07-23 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-06-27 | Material Modification to Rights of Security Holders | View | |
| 2025-06-24 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-03-28 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-11-08 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-10-29 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2024-10-29 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-10-24 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2024-10-24 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-10-22 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2024-10-22 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-09-25 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-09-24 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibit | Agreement | View |
| 2024-09-24 | Financial Statements and Exhibits | View | |
| 2024-08-21 | Other Events | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR